Adjunctive Methylene Blue in Septic Shock

Summary

Adjunctive Methylene BLUe in Septic SHock (BLUSH) is a single centre concealed-allocation parallel-group open-label randomized controlled pilot trial to ascertain the feasibility of a trial evaluating the efficacy and safety of adjunctive methylene blue infusion compared to usual care on outcomes of adult patients admitted to the intensive care unit with septic shock.

Timeline

Start

2025-06-02

Primary completion

2026-03-06

Completion

2026-03-06

Drugs

Indications